Polaryx Therapeutics, Inc. (PLYX)
Market Closed
15 Jun, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
2. 34
-0.03
-1.2658%
$
116.46M Market Cap
- P/E Ratio
- Div Yield
156,965 Volume
- Eps
$ 2.37
Previous Close Want to track PLYX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Polaryx Therapeutics, Inc. (PLYX) Statistics
Valuation metrics
Market Cap 116.46M
Enterprise value 109.12M
Trailing P/E (ttm) -17.28
Forward P/E -
PEG ratio 0.21
Price/Sales (ttm) -
Price/Book (mrq) 44.98
Enterprise Value/Revenue -
Enterprise Value/EBITDA -16.85
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 93.05K
Average volume (90 days) 339.27K
Price summary
52-Week low 2.01
52-Week high 48.91
Beta -
50-Day moving average 3.46
200-Day moving average 5.28
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.85%
Return on equity -1.66%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.14
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.07
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 3.45%
Book value per share (mrq) 0.05
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
